NCT03680352View on ClinicalTrials.gov

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 30, 2018

Conditions
PK in Patients With Various Degrees of Renal Impairment
Interventions
DRUG

cefepime/AAI101

Fixed dose combination of cefepime and AAI101

Trial Locations (2)

170 00

Pharmaceutical Research Associates CZ, s.r.o., Prague

HJ-1077

PRA Magyarország Kft Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest

Sponsors

Lead Sponsor

Allecra
All Listed Sponsors
lead

Allecra

INDUSTRY

NCT03680352 - Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects | Biotech Hunter | Biotech Hunter